Clinical trials: Exercise Tolerance

Muscle Function, Mitochondrial Function, Overweight

AMAZ-02 Effect on Exercise ToLerance in Healthy, Overweight Middle Aged Subjects (ATLAS Trial)

• Completed
• Age: 40 to 65 years

This is a Phase 2 randomized, double-blind, placebo-controlled study enrolling 90 healthy, overweight, middle aged subjects (30 placebo, 30 low dose and 30 high dose AMAZ-02 intervention), 40-65 years of age, who are otherwise…

Conditions

Muscle Function, Mitochondrial Function, Overweight, Healthy Aging

Trial name

ATLAS (NCT03464500)

Testing

Mitopure 500mg, Mitopure 1000mg

Where

Canada

Volunteers

90 people, healthy volunteers welcome

Sponsor

Amazentis SA